18 children in Uzbekistan die after consuming Indian cough syrup

The health ministry of Uzbekistan has ordered the withdrawal of all tablets and syrups of Doc-1 Max from all pharmacies in the country

Online drug sale ban: Is there a need to regulate e-pharmacies?

Following an interim ban on online sale of medicines, many questions have been raised on the need for checks and balances

India: the pharmacy of the world where ‘crazy drug combinations’ go unregulated

Of 175 drug combinations used to treat pain-relief, diabetes, anxiety/depression, and psychosis, a study found that 115 combinations had no …

Uzbekistan fallout: Union government issues ‘Ethylene Glycol (Quality Control) Order, 2022’

A joint inspection of the Noida facility of Marion Biotech has been carried out by a Uttar Pradesh Drug Control and CDSCO team

New ruse in Big Pharma's old game

Drug multinationals are lobbying for a devious patent linkage system to block the entry of competitive generics

WHO alert on ‘sub-standard’ cough syrups made by Noida firm

Alert aginst Ambronol and DOK-1 Max syrups after deaths of children in Uzbekistan

Ban recommended on import of cosmetics tested on animals

Sub-standard drugs bigger problem than counterfeit drugs: health activists

Problem of poor quality drugs cannot be solved with technology alone, they say

Is that milk safe? CSE’s assessment of antibiotic misuse in dairy sector says it’s not

A recent assessment found that dairy farmers indiscriminately use antibiotics for diseases common in animals, and is likely to aggravate the …

‘Immediate action’ needed on sub-standard drugs causing deaths: WHO

At least 300 deaths reported so far in The Gambia, Uzbekistan and Indonesia, most children

Clinical trials: illogical compensation formula

Health ministry finally drafts formula to compensate victims of drug trials. Experts wary; say formula is shoddy and ill-conceived

Government's expert panel recommends 'first come, first served' policy for registering new drugs

Activists accuse panel of pitching for pharma industry and ignoring patients' interest

Health ministry hiding facts in Indore clinical trial case?

Only one patients’ consent was not available, says health minister in Rajya Sabha

Parliament committee indicts drugs regulatory authority

Drugs which are banned in developed countries are approved in India without clinical trials

Health ministry forms committee to investigate charges by parliamentary standing committee

It will also suggest ways to improve grant of statutory approvals for drugs and functioning of the CDSCO